Submitted: 10 February 2015; Revised: 24 February 2015; Accepted: 25 February 2015; Published online first: 6 March 2015 The past year has once again been a busy one for the biosimilars industry. One of the most important milestones during 2014 was the news that the US Food and Drug Administration (FDA) had accepted
No takes yet. Share an insight, caveat, or question.
GaBI Journal Editor (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: